Cargando…

Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach

Antithrombotic therapy is the cornerstone of pharmacological treatment in patients undergoing primary percutaneous coronary intervention (PCI). However, the acute management of ST elevation myocardial infarction (STEMI) patients includes therapy for pain relief and potential additional strategies fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fabris, Enrico, Selvarajah, Abi, Tavenier, Annerieke, Hermanides, Rik, Kedhi, Elvin, Sinagra, Gianfranco, van’t Hof, Arnoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468081/ https://www.ncbi.nlm.nih.gov/pubmed/35316483 http://dx.doi.org/10.1007/s40256-022-00531-y

Ejemplares similares

Effect of prehospital treatment in STEMI patients undergoing primary PCI
por: Fabris, Enrico, et al.
Publicado: (2022)

Current and Future Insights for Optimizing Antithrombotic Therapy to Reduce the Burden of Cardiovascular Ischemic Events in Patients with Acute Coronary Syndrome
por: Selvarajah, Abi, et al.
Publicado: (2022)

Feasibility and safety of cangrelor in patients with suboptimal P2Y(12) inhibition undergoing percutaneous coronary intervention: the Dutch Cangrelor registry
por: Selvarajah, Abi, et al.
Publicado: (2021)

Exploring new insights in coronary lesion assessment and treatment in patients with diabetes mellitus: the impact of optical coherence tomography
por: Hommels, Tobias Michiel, et al.
Publicado: (2023)

Will intravenous paracetamol crush fentanyl in patients undergoing PCI for STEMI?
por: ten Berg, J. M., et al.
Publicado: (2019)

Clinical outcomes of deferred revascularisation using fractional flow reserve in patients with and without diabetes mellitus
por: Kennedy, Mark W., et al.
Publicado: (2016)

Role of tirofiban with dual antiplatelet therapy in patients with STEMI undergoing primary PCI
por: Türker, Yasin
Publicado: (2016)

The effects of tirofiban infusion on clinical and angiographic outcomes of patients with STEMI undergoing primary PCI
por: Kaymaz, Cihangir, et al.
Publicado: (2016)

Impact of COVID-19 pandemic on STEMI undergoing primary PCI treatment in Beijing, China
por: Gong, Xuhe, et al.
Publicado: (2022)

Predictors of ST Depression Resolution in STEMI Patients Undergoing Primary PCI and Its Clinical Significance
por: Ghaffari, Samad, et al.
Publicado: (2020)

Does Opioid Addiction Influence Clinical and Angiographic Outcomes in STEMI Patients Undergoing Emergency PCI?
por: Amirpour, Afshin, et al.
Publicado: (2023)

Antiplatelet strategy during ad-hoc percutaneous coronary intervention in elective patients: how aggressive should we be?
por: Selvarajah, Abi, et al.
Publicado: (2023)

High Bolus Tirofiban vs Abciximab in Acute STEMI Patients Undergoing Primary PCI – The Tamip Study
por: Balghith, Mohammed A.
Publicado: (2012)

Assessment of Growth Differentiation Factor 15 Levels on Coronary Flow in Patients with STEMI Undergoing Primary PCI
por: Dogdu, Orhan
Publicado: (2020)

Optimal pharmacological therapy in ST-elevation myocardial infarction—a review: A review of antithrombotic therapies in STEMI
por: Hermanides, R. S., et al.
Publicado: (2018)

New guidelines on primary PCI for patients with STEMI: changing insights
por: van der Wall, E.E.
Publicado: (2015)

A randomised, investigator-initiated, clinical trial of the effects of fentanyl on P2Y12-receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: rationale and design of the Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trial
por: Tavenier, A. H., et al.
Publicado: (2019)

Is ischemia the only factor predicting cardiovascular outcomes in all diabetes mellitus patients?
por: Kennedy, Mark W., et al.
Publicado: (2017)

Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores
por: Schellings, Dirk AAM, et al.
Publicado: (2016)

Index of microcirculatory resistance predicts long term cardiac systolic function in patients with STEMI undergoing primary PCI
por: Qi, Yu, et al.
Publicado: (2021)

Outcome of manual thrombus aspiration for patients undergoing primary PCI for acute STEMI showing large thrombus burden
por: Elfekky, Ehab Mohamed, et al.
Publicado: (2021)

Single-staged transfemoral transcatheter aortic valve implantation and percutaneous coronary intervention with rotablation in complex coronary artery disease: a case report
por: Postma, Warner R, et al.
Publicado: (2018)

Effect of Chinese national holidays and weekends versus weekday admission on clinical outcomes in patients with STEMI undergoing primary PCI
por: Tang, Liang, et al.
Publicado: (2017)

Impact of SARS-CoV-2 positivity on clinical outcome among STEMI patients undergoing mechanical reperfusion: Insights from the ISACS STEMI COVID 19 registry
por: De Luca, Giuseppe, et al.
Publicado: (2021)

Impact of Smoking Status on Mortality in STEMI Patients Undergoing Mechanical Reperfusion for STEMI: Insights from the ISACS–STEMI COVID-19 Registry
por: De Luca, Giuseppe, et al.
Publicado: (2022)

Impact of periprocedural morphine use on mortality in STEMI patients treated with primary PCI
por: Domokos, Dominika, et al.
Publicado: (2021)

BMI Modifies Increased Mortality Risk of Post-PCI STEMI Patients with AKI
por: Schvartz, Reut, et al.
Publicado: (2022)

LEFT LATERAL VIEW FOR PCI TREATMENT OF INFERIOR STEMI IN A PATIENT WITH DEXTROCARDIA
por: Katić, Josip, et al.
Publicado: (2022)

Complete revascularization with PCI in STEMI patients with multivessel disease, when is the appropriate time?
por: Aquino-Bruno, Heberto, et al.
Publicado: (2023)

Plasma random glucose levels at hospital admission predicting worse outcomes in STEMI patients undergoing PCI: A case series
por: Kirmani, Tooba Ahmed, et al.
Publicado: (2022)

Preventive PCI versus culprit lesion stenting during primary PCI in acute STEMI: a systematic review and meta-analysis
por: Pandit, Anil, et al.
Publicado: (2014)

Everolimus-eluting bioresorbable vascular scaffold in daily clinical practice: A single-centre experience
por: Remkes, W. S., et al.
Publicado: (2017)

IMPACT OF RENIN-ANGIOTENSIN SYSTEM INHIBITORS ON MORTALITY DURING THE COVID PANDEMIC AMONG DIABETIC PATIENTS WITH STEMI UNDERGOING MECHANICAL REPERFUSION: INSIGHT FROM AN INTERNATIONAL STEMI REGISTRY
por: De Luca, Giuseppe, et al.
Publicado: (2022)

Feasibility and safety of cangrelor in patients with suboptimal P2Y(12) inhibition undergoing percutaneous coronary intervention: rationale of the Dutch Cangrelor Registry
por: Selvarajah, A., et al.
Publicado: (2021)

A prospective, observational, multicentre study comparing tenecteplase facilitated PCI versus primary PCI in Indian patients with STEMI (STEPP—AMI)
por: Victor, Suma M, et al.
Publicado: (2014)

Infarct burden following multivessel PCI vs. infarct-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study
por: Mangion, Kenneth, et al.
Publicado: (2015)

The Tradeoff between Travel Time from Home to Hospital and Door to Balloon Time in Determining Mortality among STEMI Patients Undergoing PCI
por: Di Domenicantonio, Riccardo, et al.
Publicado: (2016)

Acute-Phase Inflammatory Reaction Predicts CMR Myocardial Scar Pattern and 2-Year Mortality in STEMI Patients Undergoing Primary PCI
por: Mester, Andras, et al.
Publicado: (2022)

Association of PCSK9 with inflammation and platelet activation markers and recurrent cardiovascular risks in STEMI patients undergoing primary PCI with or without diabetes
por: Song, Li, et al.
Publicado: (2022)

Rescue PCI in the management of STEMI: Contemporary results from the Melbourne Interventional Group registry()
por: Fernando, Himawan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v0ok2n7j4ilt646mvs0vbo0ed8